Chairman, CEO and President of Community Healthcare Trust Inc (NYSE:CHCT) Timothy G Wallace bought 4,949 shares of CHCT on 12/13/2017 at an average price of $27.6 a share. The total cost of this purchase was $136,592.
Community Healthcare Trust Inc is a real estate investment trust focusing on healthcare facilities in the United States. It leases its properties to hospitals or other healthcare service providers. Community Healthcare Trust Inc has a market cap of $499.260 million; its shares were traded at around $27.60 with a P/E ratio of 131.46 and P/S ratio of 11.11. The dividend yield of Community Healthcare Trust Inc stocks is 5.67%.
CEO Recent Trades:
Chairman, CEO and President Timothy G Wallace bought 4,949 shares of CHCT stock on 12/13/2017 at the average price of $27.6. The price of the stock has decreased by 0% since.Chairman, CEO and President Timothy G Wallace bought 10,067 shares of CHCT stock on 12/12/2017 at the average price of $27.18. The price of the stock has increased by 1.55% since.Chairman, CEO and President Timothy G Wallace bought 10,099 shares of CHCT stock on 12/11/2017 at the average price of $26.93. The price of the stock has increased by 2.49% since.Chairman, CEO and President Timothy G Wallace bought 10,047 shares of CHCT stock on 12/08/2017 at the average price of $27.33. The price of the stock has increased by 0.99% since.Chairman, CEO and President Timothy G Wallace bought 10,016 shares of CHCT stock on 12/07/2017 at the average price of $26.85. The price of the stock has increased by 2.79% since.For the complete insider trading history of CHCT, click here
Top 10 Casino Stocks To Invest In Right Now: Encana Corporation(ECA)
Encana Corporation and its subsidiaries engage in the exploration for, development, production, and marketing of natural gas, oil, and natural gas liquids. The company owns interests in resource plays that primarily include the Greater Sierra, Cutbank Ridge, Bighorn, and Coalbed Methane resource plays located in British Columbia and Alberta, as well as the Deep Panuke natural gas project offshore Nova Scotia in Canada. It also holds interests in resource plays comprising the Jonah in southwest Wyoming, Piceance in northwest Colorado, Haynesville in Louisiana, and Texas resource play, including east Texas and north Texas. The company serves primarily local distribution companies, industrials, energy marketing companies, and other producers. Encana Corporation was founded in 1971 and is headquartered in Calgary, Canada.
Advisors' Opinion:- [By Stephan Byrd]
COPYRIGHT VIOLATION NOTICE: “FDx Advisors Inc. Takes Position in Encana Corp (ECA)” was first posted by Ticker Report and is owned by of Ticker Report. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://www.tickerreport.com/banking-finance/4202858/fdx-advisors-inc-takes-position-in-encana-corp-eca.html.
- [By Jon C. Ogg]
Encana Corp. (NYSE: ECA) has seen its shares rise 19% so far in 2019, outperforming its peers by about 500 basis points. That said, Encana shares have underperformed peers by over 20% since the NFX deal announcement last November. Merrill Lynch has a Buy rating and $11 price objective on Encana, almost 60% higher than the prior $6.89 close. The firm noted that Encana's cube style completions have been an important driver of outperformance in the Permian. In the STACK, the firm expects Encana to be deliberate initially using "skinny cubes" to determine optimal vertical/horizontal spacing while targeting select zones using multi-well pads.
- [By Ethan Ryder]
Encana Corp (NYSE:ECA) (TSE:ECA) – National Bank Financial issued their FY2019 EPS estimates for shares of Encana in a report released on Tuesday, February 12th. National Bank Financial analyst T. Wood expects that the oil and gas company will post earnings of $0.61 per share for the year. National Bank Financial has a “Outperform” rating and a $18.50 price objective on the stock.
- [By Max Byerly]
Shares of Encana Corp (NYSE:ECA) (TSE:ECA) gapped up before the market opened on Tuesday . The stock had previously closed at $5.95, but opened at $6.10. Encana shares last traded at $6.11, with a volume of 65113676 shares changing hands.
Top 10 Casino Stocks To Invest In Right Now: ProQR Therapeutics N.V.(PRQR)
ProQR Therapeutics N.V. (ProQR), formerly ProQR Therapeutics B.V., is a pre-clinical stage biopharmaceutical company. The Company is engaged in the discovery and development of Ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. Utilizing its RNA repair technologies, the Company is developing a pipeline in severe genetic disorders, such as cystic fibrosis (CF) and Leber's congenital amaurosis (LCA). The Company designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of normal, or wild-type protein. The Company's product candidates include QR-010 and QR-110. The Company is focusing on developing QRX- 911, QRX- 021, QRX- 313 for Epidermolysis bullosa, QRX- 704 for Huntington's disease, QRX- 812, QRX- 411 for Usher syndrome, QRX- 504 for Fuchs, QRX- 604 for Friedreich's ataxia and QRX- 203 for Alzheimer's disease.
QR-010
The Company's lead product candidate, QR-010, is an RNA-based oligonucleotide. QR-010 is designed to address the underlying cause of the disease by repairing the mRNA defect encoded by the delta-F508 mutation in the Cystic fibrosis transmembrane conductance regulator (CFTR) gene of CF patients. The delta-F508 mutation is a deletion of over three of the coding base pairs or nucleotides, in the CFTR gene, which results in the production of a misfolded CFTR protein that does not function normally. QR-110 is designed to bind to the mutated location in the pre-mRNA, thereby leading to normally spliced or wild-type mRNA, which could produce wild-type or normal protein. QR-110 is designed to be administered through intravitreal injections in the eye.
QR-110
The Company's product candidate, QR-110, is an oligonucleotide. QR-110 is designed to treat the disease by repairing the underlying cause in the mRNA, which results in the production of wi! ld-type centrosomal protein 290 (CEP290 protein). QR-110 is designed to bind to the mutated location in the pre-mRNA, masking the cryptic splice site, thereby leading to normally spliced or wild-type mRNA, which could produce wild-type or normal protein. QR-110 is designed to be administered through intravitreal injections in the eye.
The Company competes with Vertex Pharmaceuticals Inc., Novartis International AG, Hoffmann-LaRoche Ltd., Pfizer Inc., Galapagos, AbbVie Laboratories, Shire, Sanofi, Bayer AG, Proteostasis, Corbus Pharmaceuticals, Nivalis and Gilead.
Advisors' Opinion:- [By Cory Renauer]
ProQR (NASDAQ:PRQR) is developing QR-110 to treat patients with a mutation on the same gene as EDIT-101 but in a much different manner. QR-110 would require repeat injections right in the eyes to help a mutated gene produce functional copies of the CEP290 protein, while EDIT-101 is designed to repair the gene and provide a permanent solution with a single treatment.
- [By Keith Speights]
Shares of ProQR Therapeutics N.V. (NASDAQ:PRQR) were up 16% as of 3:48 p.m. EDT on Monday. ProQR didn't report any new announcements, but the biotech's update last Wednesday from a phase 1/2 clinical study -- of RNA medicine QR-110, in treating Leber congenital amaurosis type 10 (LCA10) -- still had investors fired up.
- [By Keith Speights]
Three of the biggest winners were ProQR Therapeutics (NASDAQ:PRQR), MannKind Corp. (NASDAQ:MNKD), and Arrowhead Pharmaceuticals (NASDAQ:ARWR). Here's why these biotech stocks soared this week and a look at whether they're smart picks for investors now.
- [By Brian Feroldi]
After reporting data from a phase 1/2 clinical trial, shares of ProQR Therapeutics N.V. (NASDAQ:PRQR), a clinical-stage biotech focused on RNA medicines that treat rare genetic diseases, rose 70% as of 12:13 p.m. EDT on Wednesday.
Top 10 Casino Stocks To Invest In Right Now: SVB Financial Group(SIVB)
SVB Financial Group, a diversified financial services company, provides various banking and financial products and services. The company offers deposit products, such as traditional deposit and checking accounts, certificates of deposit, money market accounts, and sweep accounts, as well as lockbox and merchant services; and lending products and services, including traditional term loans, equipment loans, asset-based loans, revolving lines of credit, accounts-receivable-based lines of credits, capital call lines of credits, and credit cards. It also provides cash management products and services comprising wire transfer and automated clearing house payment services, collection services, disbursement services, electronic funds transfers, and online banking services. In addition, the company offers foreign exchange services; letters of credit, including export, import, and standby letters of credit; investment services and solutions; brokerage; asset management; investment a dvisory services, such as outsourced treasury services; and non-banking products and services, such as funds management, venture capital/private equity investment, and equity valuation services. Further, it provides private banking services comprising mortgages, home equity lines of credit, restricted stock purchase loans, and other secured and unsecured lending services. As of March 09, 2012, the company operated 26 offices in the United States and 7 offices internationally. It serves customers in the technology, venture capital/private equity, life science, wine, and clean tech industries. The company was founded in 1982 and is headquartered in Santa Clara, California.
Advisors' Opinion:- [By Nicholas Rossolillo (TMFnrossolillo)]
Much of the financial index's gain can be attributed to traditional banks and financial institutions recovering from the effects of the pandemic in 2020. But for Upstart Holdings (NASDAQ:UPST), SoFi Technologies (NASDAQ:SOFI), and SVB Financial Group (NASDAQ:SIVB), the story isn't about recovery. It's about all-out growth as consumers demand a new type of financial service business built for the digital age. Here's why I've been buying (or planning to buy) more of all three this summer.
- [By Logan Wallace]
SG Americas Securities LLC grew its position in shares of SVB Financial Group (NASDAQ:SIVB) by 168.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 9,929 shares of the bank’s stock after purchasing an additional 6,233 shares during the quarter. SG Americas Securities LLC’s holdings in SVB Financial Group were worth $1,886,000 as of its most recent filing with the SEC.
Top 10 Casino Stocks To Invest In Right Now: China Petroleum & Chemical Corporation(SNP)
China Petroleum & Chemical Corporation engages in the exploration, development, production, and marketing of crude oil and natural gas properties primarily in China. It operates 16 oil and gas production fields in China. As of December 31, 2010, the company?s estimated proved reserves of crude oil and natural gas consisted of 3,963 million barrels-of-oil equivalent comprising 2,888 million barrels of crude oil and 6,447 billion cubic feet of natural gas. It also engages in the refining of crude oil; marketing and distribution of refined petroleum products; and production and sale of petrochemical products that consist of intermediate petrochemicals, synthetic resins, synthetic fiber monomers and polymers, synthetic fibers, synthetic rubber, and chemical fertilizers, as well as owns and operates oil depots and service stations. The company was founded in 2000 and is based in Beijing, the People?s Republic of China. China Petroleum & Chemical Corporation is a subsidiary of China Petrochemical Corporation.
Advisors' Opinion:- [By Reuben Gregg Brewer]
The shares of China Petroleum & Chemical (NYSE:SNP), also known as Sinopec, rose 18% in January, according to data provided by S&P Global Market Intelligence. Not far behind were Canadian oil companies Vermilion Energy (NYSE:VET), with a global asset portfolio, and Suncor Energy (NYSE:SU), a Canadian oil sands specialist, with gains of 16% and 15%, respectively. U.S. based Noble Energy (NYSE:NBL), however, led this international quartet with a 19% leap. Noble's portfolio is global, but it has a material position in the U.S. onshore drilling space.
- [By Todd Campbell]
The following table highlights the 10 biggest energy companies by market capitalization. Some of these companies operate upstream, midstream, and downstream businesses, but all of them derive the majority of their revenue from upstream operations.
Rank Company Market Cap 1 ExxonMobil $348 billion 2 Royal Dutch Shell (NYSE:RDS-A)(NYSE:RDS-B) $286 billion 3 Chevron (NYSE:CVX) $223 billion 4 Petrochina Co. Ltd. (NYSE:PTR) $218 billion 5 Total SA (NYSE:TOT) $163 billion 6 BP Plc (NYSE:BP) $143 billion 7 China Petroleum (NYSE:SNP) $107 billion 8 Equinor ASA (NYSE:EQNR) $89 billion 9 ConocoPhillips (NYSE:COP) $84 billion 10 Schlumberger Ltd. (NYSE:SLB) $84 billionData source: Yahoo! Finance on Sept. 13, 2018.
Top 10 Casino Stocks To Invest In Right Now: Revlon, Inc.(REV)
Revlon, Inc., incorporated on April 24, 1992, manufactures, markets and sells around the world a range of beauty and personal care products, including color cosmetics, hair color, hair care and hair treatments, as well as beauty tools, men's grooming products, anti-perspirant deodorants, fragrances, skincare and other beauty care products. The Company operates through three segments: Consumer, Professional and Other. The Company conducts its business through its operating subsidiary, Revlon Consumer Products Corporation (Products Corporation) and its subsidiaries.
The Company maintains separate Websites, including www.revlon.com, www.almay.com, www.revloncolorsilk.com, www.revlonprofessional.com, www.americancrew.com, www.cnd.com and www.mitchum.com, dedicated to the Revlon, Almay, Revlon ColorSilk, Revlon Professional, American Crew, CND and Mitchum brands, respectively. Each of these Websites feature product and promotional information for the brands. The Company operates a research and development facility in Edison, New Jersey for products within its Consumer segment. The Company has research facilities for its products within the Professional segment in the United States (in California and Florida), Spain and Mexico. The Company's principal customers for its Consumer segment include large volume retailers and chain drug stores, including retailers, such as Walmart, CVS and Target in the United States, Shoppers DrugMart in Canada, A.S. Watson & Co. retail chains in Asia Pacific and Europe and Walgreens Boots Alliance in the United States and the United Kingdom Walmart and its affiliates around the world. The Company's principal customers for its Professional segment include Beauty Systems Group, Salon Centric and Ulta Salon, Cosmetics and Fragrance, as well as individual hair and nail salons and other distributors to professional salons.
Consumer Segment
The Company's Consumer segment includes cosmetics, hair color and hair care, beauty tools, anti-perspirant! deodorants, fragrances and skincare products sold in approximately 130 countries in large volume retailers, chain drug and food stores, chemist shops, hypermarkets, general merchandise stores, the Internet/e-commerce, television shopping, department stores, one-stop shopping beauty retailers, specialty cosmetics stores and perfumeries in the United States and internationally. The Company manufactures and markets a range of cosmetics, including face, lip, eye and nail products. The Company sells a range of cosmetics under its Revlon brand, which are designed to fulfill consumer wants and needs, and are principally priced in the upper range for large volume retailers. The Revlon brand consists of face makeup, including foundation, powder, blush and concealers; lip makeup, including lipstick, lip gloss and lip liner; eye makeup, including mascaras, eyeliners, eye shadows and brow products, and nail color and nail care lines. Its franchises within the Revlon brand include Revlon ColorStay, which offers consumers a range of products with long-wearing technology; Revlon PhotoReady products that are offered in face and eye makeup and are designed with photochromatic pigments that bend and reflect light; Revlon Age Defying, which consists of face makeup for women in the over-35 age bracket, with ingredients to help reduce the appearance of fine lines and wrinkles; Revlon Super Lustrous, which is the Company's wax-based lipcolor and is offered in a range of shades of lipstick and lip gloss, and Revlon Mascara, which consists of a collection of over five mascaras, each with a lash benefit, including lash definition, length, volume, magnified volume and length, and an all-in-one formula.
The Company's Almay brand consists of hypo-allergenic, dermatologist-tested, fragrance-free cosmetics and skincare products. The Almay brand consists of face makeup, including foundation, pressed powder, primer and concealer; eye makeup, including eye shadows, mascaras and eyeliners; lip makeup, and makeup removers. ! Franchise! s within the Almay brand include Almay Smart Shade in face; Almay Intense i-Color in eye, and Almay Color + Care in lip. The Company's SinfulColors and Pure Ice brands consist primarily of nail enamels, available in various bold, vivid and on-trend colors.
The Company sells both hair color and hair care products throughout the world to large volume retailers and other retailers, primarily under the Company's Revlon ColorSilk franchise, as well as under the premium priced Llongueras brand in Spain. Revlon ColorSilk products provide radiant, long-lasting color that leaves hair nourished, hydrated and ultra-conditioned. The Company sells Revlon beauty tools, which include nail, eye and manicure and pedicure grooming tools, eye lash curlers and a full line of makeup brushes under the Revlon brand name. The Company sells a selection of fragrances, including perfumes, eau de toilettes, colognes and body sprays. The Company's portfolio includes fragrances under globally-recognized brand names, such as Charlie and Jean Nate. The Company sells Mitchum anti-perspirant deodorant products for men and women, with ingredients that provide consumers with approximately 48 hours of protection. The Company sells skincare products in the United States and in global markets under various regional brands, including the Company's Natural Honey and Gatineau brands.
Professional Segment
The Company's Professional segment includes a line of products sold to hair and nail salons, and professional salon distributors, including hair color, shampoos, conditioners, styling products, nail polishes and nail enhancements. The Professional segment also includes a multi-cultural line sold in both professional salons, large volume retailers and other retailers. The Company's Revlon Professional brand includes hair color, hair care and hair treatment products that are distributed to professional salons, salon professionals and salon distributors, and sold in over 60 countries. Revlon Professional salo! n product! s include Revlonissimo NMT, Nutri Color Creme, Sensor Perm and Revlon Professional Equave.
The Company sells men's shampoos, conditioners, gels and other hair care, and grooming products for use and sale by professional salons under the American Crew brand name. American Crew is sold in over 30 countries. The Company also sells unisex hair products under the d:fi brand, which is a value-priced full line of cleansing, conditioning and styling products. The Company sells nail enhancement systems and nail color and treatment products and services for use by the professional nail salon industry under the CND brand name. CND offers professional nail, hand and foot care products, and CND-branded products are sold in over 75 countries. CND nail products include CND Shellac brand 14+ day nail color system, which delivers 14+ days of flawless wear, superior color and mirror shine with zero dry-time and no nail damage, and CND Vinylux weekly polish, a nail polish that uses a patent-pending technology and lasts approximately a week. While ordinary polishes become brittle and deteriorate over time, CND Vinylux dries with exposure to natural light to a flawless finish and strengthens its resistance to chips over time. The Company also sells professional hair products under brand names, such as Orofluido, UniqOne and Intercosmo. The Company sells multi-cultural hair-care products to professional salons, large volume retailers and other retailers, primarily in the United States under the Creme of Nature brand.
Other Segment
The Company's Other segment primarily includes the distribution of prestige, designer and celebrity fragrances, cosmetics and skincare products, such as Burberry and Rihanna branded products. The Other segment includes the operating results of the CBB business, which develops, manufactures, markets and distributes fragrances, and other beauty products, principally through department stores and selective distribution in international territories.
T! he Compan! y competes with L'Oreal S.A., The Procter & Gamble Company, Avon Products, Inc., Coty, Inc., Shiseido Co., Johnson & Johnson, Kao Corp., Henkel AG & Co., Mary Kay Inc., Hand & Nail Harmony, Inc., Oriflame Holding AG, Markwins International Corporation, LVMH Moet Henessy Louis Vuitton SE, Elizabeth Arden, Inc., Boots UK Limited and The Estee Lauder Companies Inc.
Advisors' Opinion:- [By Max Byerly]
Revlon (NYSE:REV) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Tuesday.
- [By Max Byerly]
An issue of Revlon Inc (NYSE:REV) bonds fell 2% as a percentage of their face value during trading on Thursday. The high-yield debt issue has a 5.75% coupon and will mature on February 15, 2021. The debt is now trading at $80.50 and was trading at $84.88 one week ago. Price moves in a company’s bonds in credit markets often anticipate parallel moves in its share price.
- [By Logan Wallace]
News headlines about Revlon (NYSE:REV) have been trending somewhat positive recently, according to Accern Sentiment. The research group rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Revlon earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the company an impact score of 47.276202232048 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Top 10 Casino Stocks To Invest In Right Now: Intec Pharma Ltd.(NTEC)
Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs. The Company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson's disease patients. Its pipeline also comprises The Accordion Pill-Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Furthermore under research is Accordion Pill-Undisclosed Drug for the prevention and treatment of small bowel non-steroidal anti-inflammatory drug (NSAID) induced ulcers. Advisors' Opinion:- [By Ethan Ryder]
Intec Pharma Ltd (NASDAQ:NTEC) – Analysts at Oppenheimer decreased their FY2019 EPS estimates for Intec Pharma in a research note issued to investors on Monday, March 4th. Oppenheimer analyst J. Olson now expects that the biotechnology company will post earnings of ($1.18) per share for the year, down from their previous forecast of ($1.04). Oppenheimer has a “Buy” rating and a $15.00 price objective on the stock. Oppenheimer also issued estimates for Intec Pharma’s FY2020 earnings at ($1.19) EPS, FY2021 earnings at ($1.56) EPS, FY2022 earnings at $0.28 EPS and FY2023 earnings at $1.18 EPS.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Intec Pharma (NTEC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Casino Stocks To Invest In Right Now: Guggenheim Build America Bonds Managed Duration Trust(GBAB)
Guggenheim Taxable Municipal Managed Duration Trust, formerly Guggenheim Build America Bonds Managed Duration Trust, is a diversified closed-end management investment company. The Trust's investment objective is to provide current income with a secondary objective of long-term capital appreciation. Under normal market conditions, the Trust will invest approximately 80% of its managed assets in taxable municipal securities, including Build America Bonds (BABs). Under normal market conditions, the Trust may invest approximately 20% of its managed assets in securities other than taxable municipal securities, including tax-exempt municipal securities, asset backed securities, senior loans and other income producing securities. It invests in a range of sectors, including power, school, university, transportation, water and sewer, hospital, investment grade corporates, city, county and preferred securities. Guggenheim Funds Investment Advisors, LLC serves as the advisor of the Trust. Advisors' Opinion:- [By Joseph Griffin]
Guggenheim Taxabl Mncpl Mngd Drtn Trst (NYSE:GBAB) declared a monthly dividend on Monday, February 4th, Wall Street Journal reports. Investors of record on Friday, February 15th will be given a dividend of 0.1257 per share by the investment management company on Thursday, February 28th. This represents a $1.51 dividend on an annualized basis and a yield of 6.67%. The ex-dividend date is Thursday, February 14th.
Top 10 Casino Stocks To Invest In Right Now: Nymox Pharmaceutical Corporation(NYMX)
Nymox Pharmaceutical Corporation, incorporated on May 30, 1995, is a biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the aging population segment. The Company markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. The Company also has a range of patent portfolio covering its marketed products, its investigational drug, as well as other therapeutic and diagnostic indications. The Company also has the United States and global patent rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The Company's subsidiaries include Nymox Corporation and Serex, Inc. Nymox Corporation conducts research and development, while Serex, Inc. conducts research and development, and manufacturing of NicAlert and TobacAlert.
The Company's NicAlert and TobacAlert are the test strips, which determine whether a person is using tobacco products (NicAlert) or has been exposed to second-hand smoke (TobacAlert). Both NicAlert and TobacAlert provide a read-out of levels of cotinine, a by-product of the body's breakdown of nicotine and regarded as the indicator of tobacco exposure for smokers and non-smokers. The technology can be used with saliva, as well as urine samples in order to detect tobacco product use. The Company's AlzheimAlert is a urine assay that can aid physicians in the diagnosis of Alzheimer's disease. The Company has developed a kit version of the AlzheimAlert assay for sale in Europe. The kit allows clinical reference laboratories to perform the AlzheimAlert assay on site with urine samples sent directly to the laboratory.
The Company is developing treatments for BPH. The Company's lead candidate NX-1207 completed a multi-center, double-blind, placebo-controlled Phase II trial. The ! Company is in the process of further data analysis and assessments of the two studies. The Company is also developing NX-1207 as a focal treatment for certain types of cancer. The Company initiated a Phase II clinical trial in the United States. The Company enrolled approximately 147 patients at over 28 clinical centers across the United States to evaluate its NX-1207 drug for the treatment of low-grade localized prostate cancer.
The Company competes with LabCorp, Quest Diagnostics, OraSure Technologies Inc., Abraxis LLC, Roche Diagnostics, Abbott, Siemens Medical Solutions, Mossman & Associates Ltd, GFC Diagnostics Ltd., Lilly and GE Healthcare.
Advisors' Opinion:- [By Logan Wallace]
IDEXX Laboratories (NASDAQ: IDXX) and Nymox Pharmaceutical (NASDAQ:NYMX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership.
Top 10 Casino Stocks To Invest In Right Now: BlackRock Multi-Sector Income Trust(BIT)
BlackRock Multi-Sector Income Trust is a closed-end management investment company. The Trust's primary investment objective is to seek high current income, with a secondary objective of capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, approximately 80% of its assets in loan and debt instruments and other investments. It may invest directly in such securities or synthetically through the use of derivatives. Its portfolio of investments include corporate bonds, non-agency mortgage-backed securities, asset-backed securities, preferred securities, floating rate loan interests, foreign agency obligations and short-term securities. It invests in sectors, such as aerospace and defense, auto components, banks, building products, commercial services and supplies, construction materials, electric utilities, food and staples retailing, media and household durables. The Trust's investment advisor is BlackRock Advisors, LLC. Advisors' Opinion:- [By Ethan Ryder]
Northwestern Mutual Wealth Management Co. increased its stake in Blackrock Multi-Sector Income Trust (NYSE:BIT) by 23.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 82,769 shares of the investment management company’s stock after purchasing an additional 15,675 shares during the quarter. Northwestern Mutual Wealth Management Co. owned 0.22% of Blackrock Multi-Sector Income Trust worth $1,415,000 at the end of the most recent quarter.
- [By Max Byerly]
BitRewards (CURRENCY:BIT) traded 7.8% lower against the US dollar during the 24-hour period ending at 19:00 PM E.T. on August 13th. One BitRewards token can now be purchased for approximately $0.0017 or 0.00000027 BTC on exchanges including IDEX and HitBTC. BitRewards has a total market capitalization of $414,691.00 and $106,200.00 worth of BitRewards was traded on exchanges in the last 24 hours. Over the last week, BitRewards has traded down 31.6% against the US dollar.
- [By Shane Hupp]
First Bitcoin (CURRENCY:BIT) traded up 12.4% against the US dollar during the one day period ending at 7:00 AM E.T. on July 1st. One First Bitcoin coin can now be bought for approximately $0.0113 or 0.00000177 BTC on major exchanges. Over the last week, First Bitcoin has traded 4% lower against the US dollar. First Bitcoin has a market capitalization of $0.00 and approximately $13.00 worth of First Bitcoin was traded on exchanges in the last day.
Top 10 Casino Stocks To Invest In Right Now: Host Hotels & Resorts, Inc.(HST)
Host Hotels & Resorts, Inc. (Host Inc.), incorporated on September 28, 1998, operates as a self-managed and self-administered real estate investment trust (REIT). The Company operates through hotel ownership segment. The Company owns properties and conducts operations through Host Hotels & Resorts, L.P. (Host L.P.), of which Host Inc. is the sole general partner and in which it holds approximately 99% of the partnership interests (OP units). The Company's portfolio consists of luxury and upper upscale properties located in the central business districts of cities, near airports and resort/conference destinations. In addition to its consolidated hotel portfolio, the Company also owns non-controlling interests in several entities and owned interest in approximately 20 hotel properties.
The Company's lodging portfolio consists of over 100 luxury and upper-upscale hotels containing approximately 57,000 rooms, with the majority located in the United States and with approximately 20 of the properties located outside of the United States, in Australia, Brazil, Canada, Chile, Mexico and New Zealand. In addition, the Company owns non-controlling interests in two international joint ventures: a joint venture in Europe, which owns approximately 10 luxury and upper upscale hotels with approximately 3,900 rooms in Belgium, France, Germany, Spain, Sweden, the Netherlands and the United Kingdom, and another joint venture, which holds interest in approximately five operating hotels in India and over two additional hotels, which are under development. It also holds non-controlling investments in approximately two domestic hotels and a timeshare joint venture in Hawaii. The Company's hotels operate in urban and resort markets under brand names as Fairmont, Grand Hyatt, JW Marriott, Ritz-Carlton, St. Regis, The Luxury Collection and W, or as upper upscale properties under brand names as Embassy Suites, Hilton, Hyatt, Le Meridien, Marriott Executive Apartments, Marriott Marquis, Marriott Suites, Pullman, Ren! aissance, Sheraton, Swissotel and Westin.
Advisors' Opinion:- [By Shane Hupp]
Get a free copy of the Zacks research report on Host Hotels and Resorts (HST)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Decision Token (CURRENCY:HST) traded up 0.4% against the U.S. dollar during the 1-day period ending at 23:00 PM ET on August 1st. Over the last seven days, Decision Token has traded 14.3% lower against the U.S. dollar. Decision Token has a total market cap of $9.44 million and approximately $37,782.00 worth of Decision Token was traded on exchanges in the last day. One Decision Token token can now be purchased for $0.29 or 0.00003853 BTC on major exchanges including Cryptopia, Livecoin and Kucoin.
- [By Shane Hupp]
Krueger & Catalano Capital Partners LLC acquired a new stake in Host Hotels and Resorts Inc (NYSE:HST) during the second quarter, HoldingsChannel.com reports. The fund acquired 42,846 shares of the real estate investment trust’s stock, valued at approximately $903,000.
No comments:
Post a Comment